David Linn Lockhart

age ~61

from Collierville, TN

Get Report

Also known as:

David L Lockhart
David Lockheart
Dave Lockheart

Connected to:

David Lockhart Phones & Addresses

Collierville, TN
Brighton, TN
Belcamp, MD
San Clemente, CA
Buchanan, TN
Baltimore, MD
Murray, KY
10931 Meadowbirch Ln, Collierville, TN 38017

Work

Position:

Clerical/White Collar

Education

Degree:

High school graduate or higher

Name / Title

Company / Classification

Phones & Addresses

Mr. David Lockhart
Owner

Lockhart Truck Center
Lockhart Truck Centre
Truck Dealers

100 Thornhill Drive, Dartmouth, NS B3B 1S3
9024685900, 9024687490

Mr. David Lockhart
General Manager

East Coast International Trucks - Moncton
Auto Dealers - Used Cars

100 Urquhart Avenue, Moncton, NB E1H 2R5
5068572864

Mr. David Lockhart
Owner

Lockhart's Tree Service
Tree Services

1811 12th St., #B, Lawrenceville, IL 62439
6189433973

David Lockhart
Owner

Lockhart Truck Center
Truck Dealers

9024685900, 9024687490

David Lockhart
General Manager

East Coast International Trucks - Moncton
Auto Dealers - Used Cars

5068572864

David Lockhart

LOCKHART AUTOMOTIVE LLC

David Lockhart
Chief Technology Officer

CalAmp
Wireless · Sales And Technical Support · Whol Electronic Parts/Equipment · Mfg Wireless Products Engineering Services & Software · Mfg Wireless Products Engineering Services and Software · Radio and Television Broadcasting and Wireless Communication · Radio/Tv Broadcasting/Comm Equ · Audio and Video Equipment Manufacturing

1401 N Rice Ave, Oxnard, CA 93030
Attn: Rick Vitelle, Oxnard, CA 93030
300 W Clarendon Ave #230, Phoenix, AZ 85013
1401 N, Oxnard, CA 93030
7703920002, 8059879000, 8059878359

Lawyers & Attorneys

David James Lockhart - Lawyer

view source

Licenses:

Montana - Active 2009

David A Lockhart - Lawyer

view source

Licenses:

Dist. of Columbia - Legal Consultant 2003

David R Lockhart

Medicine Doctors

David W. Lockhart

view source

Specialties:

Family Medicine

Work:

Family Medicine AssociatesBlessing Physician Services
927 Broadway St STE 302, Quincy, IL 62301
2172246423 (phone), 2172215581 (fax)

Education:

Medical School
Indiana University School of Medicine
Graduated: 1976

Procedures:

Arthrocentesis
Destruction of Benign/Premalignant Skin Lesions
Skin Tags Removal
Vaccine Administration

Conditions:

Acute Conjunctivitis
Anxiety Dissociative and Somatoform Disorders
Atrial Fibrillation and Atrial Flutter
Bronchial Asthma
Chronic Renal Disease

Languages:

English
Spanish

Description:

Dr. Lockhart graduated from the Indiana University School of Medicine in 1976. He works in Quincy, IL and specializes in Family Medicine. Dr. Lockhart is affiliated with Blessing Hospital.

Us Patents

Amide Derivatives As Abl Modulators
view source
US Patent:

20050148605, Jul 7, 2005
Filed:

Nov 15, 2004
Appl. No.:

10/989745
Inventors:

Robert Grotzfeld - Carlsbad CA, US
Hitesh Patel - Encinitas CA, US
Shamal Mehta - San Diego CA, US
Zdravko Milanov - San Diego CA, US
Andiliy Lai - San Diego CA, US
David Lockhart - Del Mar CA, US
International Classification:

A61K031/52
A61K031/517
US Classification:

514263200, 514266230
Abstract:

The invention provides methods and compositions for treating conditions mediated by abl wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Conjugated Small Molecules
view source
US Patent:

20050153371, Jul 14, 2005
Filed:

Jan 7, 2005
Appl. No.:

11/031638
Inventors:

Robert Grotzfeld - Carlsbad CA, US
Zdravko Milanov - San Diego CA, US
Hitesh Patel - Encinitas CA, US
Andiliy Lai - San Diego CA, US
Shamal Mehta - San Diego CA, US
David Lockhart - Del Mar CA, US
International Classification:

C12Q001/68
G01N033/53
C07H019/04
A61K031/7076
A61K031/4188
A61K031/52
A61K031/506
A61K031/4745
C07D498/02
US Classification:

435007500, 514047000, 514252170, 514275000, 514292000, 514393000, 514234200, 514253060, 514263200, 536026100, 544277000, 544330000, 544284000, 548304100, 514218000, 540575000
Abstract:

Provided herein are linker compounds and conjugates that include the linker compounds. In one embodiment, the linker compounds comprise 2 or 3 residues of 6-aminohexanoic acid and optionally 7-10 residues of polyethyleneglycol (PEG). The linker compounds are useful in forming conjugates with one or more components useful in biopharmaceutical or bioanalytical applications. In particular, the biopharmaceutically useful compounds are kinase inhibitors. The conjugates described herein have utility in a variety of diagnostic, separation, and therapeutic applications.

Pyrrolopyrimidine Derivatives And Analogs And Their Use In The Treatment And Prevention Of Diseases
view source
US Patent:

20050153989, Jul 14, 2005
Filed:

Jan 13, 2005
Appl. No.:

11/036241
Inventors:

Robert Grotzfeld - Carlsbad CA, US
Hitesh Patel - Encinitas CA, US
Shamal Mehta - San Diego CA, US
Zdravko Milanov - San Diego CA, US
Andiliy Lai - San Diego CA, US
David Lockhart - Del Mar CA, US
International Classification:

A61K031/519
A61K031/52
US Classification:

514260100, 514263400, 514265100
Abstract:

Described herein are compounds and compositions for modulating kinase activity, and methods for modulating kinase activity using the compounds and compositions. Also described herein are methods of using the compounds and/or compositions in the treatment and prevention of a variety of diseases and unwanted conditions in subjects.

Urea Derivatives As Abl Modulators
view source
US Patent:

20050165031, Jul 28, 2005
Filed:

Nov 15, 2004
Appl. No.:

10/989814
Inventors:

Robert Grotzfeld - Carlsbad CA, US
Shamal Mehta - San Diego CA, US
Zdravko Milanov - San Diego CA, US
Andiliy Lai - San Diego CA, US
David Lockhart - Del Mar CA, US
International Classification:

A61K031/52
A61K031/519
A61K031/517
US Classification:

514263200, 514265100, 514266200
Abstract:

The invention provides methods and compositions for treating conditions mediated by Bcr-Abl. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Amide Derivatives As C-Kit Modulators
view source
US Patent:

20050165074, Jul 28, 2005
Filed:

Nov 15, 2004
Appl. No.:

10/990007
Inventors:

Robert Grotzfeld - Carlsbad CA, US
Zdravko Milanov - San Diego CA, US
Shamal Mehta - San Diego CA, US
Andiliy Lai - San Diego CA, US
Hitesh Patel - Encinitas CA, US
David Lockhart - Del Mar CA, US
International Classification:

A61K031/42
US Classification:

514378000
Abstract:

The invention provides methods and compositions for treating conditions mediated by c-kit wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Treatment Of Diseases With Kinase Inhibitors
view source
US Patent:

20060234931, Oct 19, 2006
Filed:

Jul 19, 2004
Appl. No.:

10/894877
Inventors:

William Biggs - San Clemente CA, US
Todd Carter - San Diego CA, US
Miles Fabian - La Jolla CA, US
David Lockhart - Del Mar CA, US
Patrick Zarrinkar - San Diego CA, US
Daniel Treiber - San Diego CA, US
Phillip Edeen - Poway CA, US
International Classification:

A61K 38/54
US Classification:

514012000
Abstract:

The invention is directed to the identification and use of additional targets of BIRB 796, imatinib mesylate, and BAY 43-9006. The new targets of BIRB 796, imatinib mesylate, and BAY 43-9006 can be used to screen for suitable therapeutic compounds. Also, novel therapeutic and prophylactic uses for BIRB 796, imatinib mesylate, and BAY 43-9006 are disclosed herein.

Conjugated Small Molecules
view source
US Patent:

20100048890, Feb 25, 2010
Filed:

Jun 30, 2009
Appl. No.:

12/495526
Inventors:

Robert M. Grotzfeld - Carlsbad CA, US
Zdravko V. Milanov - San Diego CA, US
Hitesh K. Patel - Encinitas CA, US
Andiliy G. Lai - San Diego CA, US
Shamal A. Mehta - San Diego CA, US
David J. Lockhart - Del Mar CA, US
International Classification:

C07D 498/22
C07D 473/16
C07D 471/04
US Classification:

540545, 544277, 544279
Abstract:

Provided herein are linker compounds and conjugates that include the linker compounds. In one embodiment, the linker compounds comprise 2 or 3 residues of 6-aminohexanoic acid and optionally 7-10 residues of polyethyleneglycol (PEG). The linker compounds are useful in forming conjugates with one or more components useful in biopharmaceutical or bioanalytical applications. In particular, the biopharmaceutically useful compounds are kinase inhibitors. The conjugates described herein have utility in a variety of diagnostic, separation, and therapeutic applications.